New drug for stiff person syndrome granted designation to speed up development: ‘Thrilled for the community’

Fox News

Right

Mixed Factuality

Media Conglomerate: Murdoch Family

Media Conglomerate: Rupert Murdoch

New drug for stiff person syndrome granted designation to speed up development: ‘Thrilled for the community’

Patients with stiff person syndrome are one step closer to having access to a new treatment.Kyverna Therapeutics’ new drug, KYV-101, has been designated by the U.S. Food and Drug Administration (FDA) a Regenerative Medicine Advanced Therapy (RMAT), the company announced on Monday.A drug is eligible for RMAT designation if it is "intended to treat, modify, reverse or cure a serious or life-threatening disease or condition" and if "preliminary cli…